Literature DB >> 10533922

Near-infrared optical properties of ex vivo human uterus determined by the Monte Carlo inversion technique.

P M Ripley1, J G Laufer, A D Gordon, R J Connell, S G Bown.   

Abstract

The optical properties, absorption (mua) and reduced scattering coefficient (mu's), of ex vivo human myometrium and leiomyoma (fibroid) have been determined by the Monte Carlo inversion technique over the wavelength range 600-1000 nm. This region is currently of interest for new, minimal-access, surgical laser procedures such as photodynamic therapy (PDT) for abnormalities of the uterus, and interstitial laser photocoagulation (ILP) for the thermal ablation of fibroids. In the region 630-675 nm (corresponding to PDT), the optical coefficients of myometrium are mua = 0.041+/-0.012 mm(-1) and mu's = 1.37+/-0.19 mm(-1). For the wavelength range 800-1000 nm (associated with infrared lasers for ILP), the optical coefficients of fibroid were found to be mua = 0.020+/-0.003 mm(-1) and mu's = 0.56+/-0.03 mm(-1). Overall, the optical properties of fibroid were found to be lower than myometrium, and this was attributed to the differences in both anatomy and vascularity. The results show that PDT for ablation of the uterine endometrium is most unlikely to affect any tissues beyond the myometrium, and that the region around 800 nm is the most effective for ablation of fibroids using ILP as the penetration depth of light is greatest at this wavelength.

Entities:  

Mesh:

Year:  1999        PMID: 10533922     DOI: 10.1088/0031-9155/44/10/307

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  2 in total

1.  Optode Design Space Exploration for Clinically-robust Non-invasive Fetal Oximetry.

Authors:  Daniel D Fong; Vivek J Srinivasan; Kourosh Vali; Soheil Ghiasi
Journal:  ACM Trans Embed Comput Syst       Date:  2019-10-08       Impact factor: 1.193

2.  Computational analysis of endometrial photocoagulation with diffusing optical device.

Authors:  Jinhee Kwon; Chang-Yong Lee; Junghwan Oh; Hyun Wook Kang
Journal:  Biomed Opt Express       Date:  2013-10-14       Impact factor: 3.732

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.